Palisade Bio (PALI) Preferred Shares (2016 - 2026)

Palisade Bio (PALI) reported Preferred Shares of $2000.0 for Q1 2026, little changed year-over-year from $2000.0 in Q1 2025, and little changed quarter-over-quarter from $2000.0 in Q4 2025.

Palisade Bio (PALI) Preferred Shares (2016 - 2026) Analysis & Trends

Palisade Bio (PALI) has 11 years of Preferred Shares data on file, last reported at $2000.0 in Q1 2026.

  • Preferred Shares for Q1 2026 came in at $2000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2000.0 (changed 0.0% YoY), and the FY2025 annual result was $2000.0, changed 0.0% from the prior year.
  • Preferred Shares was little changed at $2000.0 in Q1 2026 per PALI's latest filing, from $2000.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $2000.0 in Q1 2022 and troughed at $2000.0 in Q1 2022.
  • A 5-year average of $2000.0 and a median of $2000.0 in 2022 frame the typical range for Preferred Shares.
  • On a YoY basis, Preferred Shares climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
  • A 5-year view of Preferred Shares shows it stood at $2000.0 in 2022, then changed by 0.0% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025, then changed by 0.0% to $2000.0 in 2026.
  • Business Quant data shows PALI's Preferred Shares at $2000.0 in Q1 2026, $2000.0 in Q4 2025, and $2000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Palisade Bio 391.02 Mn 261.45 Mn - 2,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2,000.00
Dec 31, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 2,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 2,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 2,000.00
Mar 31, 2023 2,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 2,000.00
Jun 30, 2021 2,000.00